Has Alpine Immune Sciences Found the Deal of a Lifetime?
Alpine Immune Sciences shares doubled on Thursday after the company announced a license agreement with AbbVie for its ALPN-101.
All Work
Chris Lange
Kroger Earnings: When Good Isn’t Good Enough
Kroger reported better than expected fiscal first-quarter financial results before the markets opened on Thursday, but shares retreated on a lack of guidance.
Why This Analyst Sees Beyond Meat’s Prospects Improving
Beyond Meat has announced a new product line just in time for summer, and one key analyst has hiked his target price for the faux meat firm as well.
One Analyst Has Risked a Big Buy Rating on Nikola Stock
Nikola shares saw a handy gain on Wednesday after the first analyst got behind this electric vehicle manufacturer.
Aclaris Therapeutics Takes the Next Big Step Toward COVID Treatment
Aclaris Therapeutics has received an update from FDA regarding the use of its ATI-450 in hospitalized patients with COVID-19.
DraftKings Decides to Capitalize With Secondary Offering
Companies usually pursue secondary offerings as a way to raise capital after their stock has made a solid run. This is the case with DraftKings.
Is Groupon Back on Track After Q1?
Groupon reported first-quarter financial results after markets closed on Tuesday. The company said that it had a net loss of $1.63 per share and $374.2 million in revenue, beating analysts' consensus estimates on both…
Are Oracle Earnings Good Enough For Investors?
Oracle released fiscal fourth-quarter results after markets closed Tuesday. The firm reported $1.20 in earnings per share and $10.44 billion in revenue. Consensus estimates called for $1.16 in EPS and revenue of $10.67 billion.
How Weight Watchers’ Parent Just Became the Newest COVID-19 Stock
Weight Watchers is looking to deal with the excess weight that some people may have put on during the pandemic stay-at-home period.
Royalty Pharma Enters the Market With a Bang
Royalty Pharma shares entered the market with a bang on Tuesday.
Why This Analyst Just Got Very Bullish on the iPhone 12
Apple has largely weathered the coronavirus pandemic on the back of its Services business, but Wedbush Securities sees it rising even higher on its bread and butter business — iPhone sales.
How Digital Ally Is Holding Police Officers More Accountable
Digital Ally stock looks to be done running for now, though it easily could pick up again, as demand for body cameras remains incredibly high.
Meet Sanofi’s Big New Investment Into a COVID-19 Vaccine
Sanofi's announcement that it would be investing in a COVID-19 vaccine production site in France gave shares a boost early Tuesday.
Daunting Flight, Simulator Tests Lie Ahead for Boeing Stock
Even when the 737 Max is cleared to fly again, Boeing will have to deal with reduced demand and increased oversight.
Canaccord Genuity’s Top Biopharma Catalysts for the Rest of 2020
Canaccord Genuity recently released a report detailing some of the biggest biotech catalysts coming out over these next six months.
Genius Brands Gets Even Stronger With Celebrity Addition
Genius Brands shares pumped up again on Monday after the company announced that Arnold Schwarzenegger would be starring and co-producing a new animated series, as well as taking a stake in the company.
Digital Ally Continues Its Surge on Body Cam Demand
Digital Ally shares pushed higher on Monday, continuing their run higher as demand for body cams increases hand in hand with civil unrest across the country.
Partnerships Creating a Bright Future for AMD Stock
AMD is partnering with Amazon, Microsoft and Sony and helping to fight the coronavirus.
Meet Shopify and Walmart’s New Partnership
Shopify shares shot up to start out the week after Walmart announced a partnership with the Canadian e-commerce company.
Groupon, Kroger, Lennar, Oracle and More Earnings Coming This Week
24/7 Wall St. offers a preview of what to expect from some of the key companies on deck to report quarterly results this week, including Kroger and Oracle.